GSK plc
GLAXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4 | $3 | $4 | $4 |
| Short-Term Investments | $0 | $2 | $4 | $0 |
| Receivables | $6 | -$0 | $7 | $8 |
| Inventory | $6 | $5 | $5 | $6 |
| Other Curr. Assets | $2 | $8 | $8 | $9 |
| Total Curr. Assets | $17 | $19 | $21 | $19 |
| Property Plant & Equip (Net) | $10 | $10 | $10 | $11 |
| Goodwill | $7 | $7 | $7 | $11 |
| Intangibles | $16 | $15 | $14 | $30 |
| Long-Term Investments | $1 | $1 | -$3 | $2 |
| Tax Assets | $7 | $0 | $6 | $5 |
| Other NC Assets | $2 | $8 | $5 | $2 |
| Total NC Assets | $42 | $40 | $39 | $60 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $59 | $59 | $60 | $79 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $4 | $5 |
| Short-Term Debt | $2 | $3 | $4 | $4 |
| Tax Payable | $1 | $1 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $2 |
| Other Curr. Liab. | $15 | $14 | $15 | $15 |
| Total Curr. Liab. | $22 | $21 | $23 | $24 |
| LT Debt | $15 | $15 | $17 | $21 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $4 |
| Other NC Liab. | $9 | $10 | $10 | $10 |
| Total NC Liab. | $25 | $25 | $27 | $34 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $1 |
| Total Liabilities | $46 | $46 | $50 | $58 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | $8 | $7 | $4 | $8 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $5 | $5 | $5 | $6 |
| Total Equity | $14 | $13 | $11 | $15 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$1 | -$1 | $6 |
| Total Liab. & Tot. Equity | $59 | $59 | $60 | $79 |
| Net Debt | $13 | $15 | $17 | $20 |